Tumor News and Research

RSS

Promega and Merck collaborate to develop MSI companion diagnostic for use with anti-PD-1 therapy

Promega Corporation today announced it has entered into a global collaboration with Merck, to develop Promega’s microsatellite instability technology.

From Promega Corporation 8 Nov 2019

Hitachi and CLB in Lyon-France announce research collaboration to fight against cancer with AI

Hitachi, Ltd. and Centre Leon Berard (CLB), a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.

8 Nov 2019

UK to be transformed into global hub for next-generation radiotherapy research

The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today (Monday).

8 Nov 2019

Vitamin D and omega-3 fatty acids are not effective at reducing systemic inflammation

Vitamin D and marine omega-3 fatty acids -- also known as fish oil -- are purported to have many health benefits, including reducing systemic inflammation.

7 Nov 2019

New molecule can reduce aggressiveness of embryonal central nervous system tumors

In Brazil, scientists affiliated with the Human Genome and Stem Cell Research Center (HUG-CELL) at the University of São Paulo (USP) have identified a molecule capable of reducing the aggressiveness of embryonal central nervous system tumors.

7 Nov 2019

Experimental drug targets currently untreatable type of lung cancer

Scientists at Stanford and UC-San Francisco have developed an experimental drug that targets a currently untreatable type of lung cancer responsible for generating roughly 500,000 newly diagnosed cases worldwide each year.

7 Nov 2019

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Using cells from human breast cancers and mouse breast cancer models, researchers at the Johns Hopkins Kimmel Cancer Center say they have significant new evidence that tumor cells exposed to low-oxygen conditions have an advantage when it comes to invading and surviving in the bloodstream.

7 Nov 2019

Researchers seek to replace metal collimators with plastic analogs made by 3D printer

Nowadays, electron beam radiotherapy is conducted using metal collimators for the formation of radiation field around a tumor and protection of healthy organs and tissues.

7 Nov 2019

Hitachi and CLB establish new research laboratory to improve diagnosis, treatment of cancer

Hitachi, Ltd. and Centre Leon Berard, a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.

6 Nov 2019

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

The University of Texas MD Anderson Cancer Center, Artios Pharma Limited and ShangPharma Innovation today announce the in-licensing by Artios of a small-molecule ATR inhibitor program, developed jointly by MD Anderson and ShangPharma.

6 Nov 2019

Nanotechnologies can lead to big advances in cancer therapy

Nami Therapeutics Corporation, which gets its name from the Mandarin word for "nano," is committed to using nanotechnologies to make big advances in cancer therapy.

6 Nov 2019

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.

6 Nov 2019

Blood test combined with AI program could speed up diagnosis of brain tumors

Chemical analysis of blood samples, combined with an artificial intelligence program, could speed up the diagnosis of brain tumors, according to research presented at the 2019 NCRI Cancer Conference.

5 Nov 2019

Novel detection method for retinoblastoma

A retinoblastoma is a dangerous cancer often occurring in very young children, under 2, which can cause blindness or the loss of the eye. The tumor is a diffuse, gluey mass spread all over the eye. It also spreads easily. As a result of this, direct biopsy is impossible, unlike with most other tumors. Instead, eye examination by ophthalmologists (eye specialists) and ultrasound imaging are needed to make a diagnosis.

5 Nov 2019

Researchers identify potential drug targets for glioblastoma

Researchers at Karolinska Institutet in Sweden have identified 10 tumor-specific potential drug targets for the brain tumor glioblastoma. The results are presented in the scientific journal Cell Reports.

5 Nov 2019

Tumor cell plasticity counts during cancer metastasis

Cancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality.

5 Nov 2019

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

The Human Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

5 Nov 2019

Researchers discover new process of antitumor response of NK cells in myeloma

NK cells mean Natural Killer cells. They are part of the innate immune system. They are known primarily for their ability to recognize and kill tumor cells, cells infected by viruses and bacteria, or dying by apoptosis. Although evidence about their antitumoral capacity, how this activity occurred remained unknown.

5 Nov 2019

The Achilles heel of APC-mutated colon tumors identified

In almost all cases of colon cancer, a specific gene is mutated – this offers opportunities to develop broadly effective therapeutic approaches. Research teams in Würzburg have taken this a step further.

5 Nov 2019

Biomarker reveals if benign-appearing meningiomas are dangerous

A modified protein in benign-appearing meningiomas can reveal which are truly benign and which are more dangerous and require more aggressive treatment, researchers have discovered.

5 Nov 2019

Tumor News and Research

Promega and Merck collaborate to develop MSI companion diagnostic for use with anti-PD-1 therapy

Hitachi and CLB in Lyon-France announce research collaboration to fight against cancer with AI

UK to be transformed into global hub for next-generation radiotherapy research

Vitamin D and omega-3 fatty acids are not effective at reducing systemic inflammation

New molecule can reduce aggressiveness of embryonal central nervous system tumors

Experimental drug targets currently untreatable type of lung cancer

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Researchers seek to replace metal collimators with plastic analogs made by 3D printer

Hitachi and CLB establish new research laboratory to improve diagnosis, treatment of cancer

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

Nanotechnologies can lead to big advances in cancer therapy

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

Blood test combined with AI program could speed up diagnosis of brain tumors

Novel detection method for retinoblastoma

Researchers identify potential drug targets for glioblastoma

Tumor cell plasticity counts during cancer metastasis

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

Researchers discover new process of antitumor response of NK cells in myeloma

The Achilles heel of APC-mutated colon tumors identified

Biomarker reveals if benign-appearing meningiomas are dangerous

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News